ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that Robert E. Conway, has been appointed to the Company’s Board of Directors. He will serve on the Audit and Compensation Committees of the Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
